The Epoch Times
The Epoch Times
Focus

new drug

Health News
Health News
|
A.C. Dahnke

Survey Shows Doctors Have Limited Knowledge of FDA Approval Protocol

Over half of American doctors are under the impression the FDA approval process for new drugs and medical devices is more rigorous than it actually is.
Jan 16, 2024
|
A.C. Dahnke
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Survey Shows Doctors Have Limited Knowledge of FDA Approval Protocol
Jan 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
Australia News
|
AAP

New Heart Condition Drug Listed on PBS

Jan 30, 2021
|
AAP
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
New Heart Condition Drug Listed on PBS
Jan 30
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Health
Health
|
Epoch Video

Double Chin-Fighting Injectable Drug a Possibility (Video)

Feb 01, 2015
|
Epoch Video
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Double Chin-Fighting Injectable Drug a Possibility (Video)
Feb 01
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Health News
Health News
|
A.C. Dahnke

Survey Shows Doctors Have Limited Knowledge of FDA Approval Protocol

Over half of American doctors are under the impression the FDA approval process for new drugs and medical devices is more rigorous than it actually is.
Jan 16, 2024
|
A.C. Dahnke
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Survey Shows Doctors Have Limited Knowledge of FDA Approval Protocol
Jan 16
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
Australia News
|
AAP

New Heart Condition Drug Listed on PBS

Jan 30, 2021
|
AAP
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
New Heart Condition Drug Listed on PBS
Jan 30
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Health
Health
|
Epoch Video

Double Chin-Fighting Injectable Drug a Possibility (Video)

Feb 01, 2015
|
Epoch Video
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Double Chin-Fighting Injectable Drug a Possibility (Video)
Feb 01
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.